Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime-Avibactam in Pediatric Patients Aged 3 Months and Older.
Increasing prevalence of infections caused by antimicrobial-resistant Gram-negative bacteria...
Read More